For research use only. Not for therapeutic Use.
SRD5A1-IN-1（Cat No.:I042360）is a selective inhibitor of the enzyme 5α-reductase type 1 (SRD5A1), which plays a key role in the conversion of testosterone to dihydrotestosterone (DHT). DHT is a potent androgen involved in various physiological processes, including prostate growth and hair loss. By inhibiting SRD5A1, SRD5A1-IN-1 has potential therapeutic applications in conditions such as androgenic alopecia (hair loss) and benign prostatic hyperplasia (BPH). Research is ongoing to explore its effectiveness in managing these disorders, particularly in cases where traditional treatments targeting androgen pathways may not be fully effective.
| CAS Number | 2279077-93-7 |
| Synonyms | (E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide |
| Molecular Formula | C17H11F6NO3 |
| Purity | ≥95% |
| IUPAC Name | (E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide |
| InChI | InChI=1S/C17H11F6NO3/c18-16(19,20)10-6-11(17(21,22)23)8-12(7-10)24-15(27)4-2-9-1-3-13(25)14(26)5-9/h1-8,25-26H,(H,24,27)/b4-2+ |
| InChIKey | VYSOCZLQZPSHHE-DUXPYHPUSA-N |
| SMILES | C1=CC(=C(C=C1/C=C/C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O)O |
